Re-Connect Application for Smoking Cessation

NCT ID: NCT05224154

Last Updated: 2025-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

82 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-14

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This series of studies will explore the acceptability, feasibility, and preliminary efficacy of making access to smartphone applications contingent on objective evidence of smoking abstinence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim 1 will use small focus groups and feedback sessions (n = 4-6) to gain insight into the acceptability and usability of Re-Connect. Up to 3 single-case design studies (n = 4/round) will then be conducted to get more extended use of the app in a real world context to get additional information about usability and acceptability of the app. Aim 2 will involve a 2-group (AC vs SC), pilot randomized control trial to test the feasibility, acceptability, and preliminary efficacy of Re-Connect.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation Acceptability of Health Care Nicotine Dependence, Cigarettes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Aim 1 will use small focus groups and feedback sessions (n = 4-6) to gain insight into the acceptability and usability of Re-Connect. Up to 3 single-case design studies (n = 4/round) will then be conducted to get more extended use of the app in a real world context to get additional information about usability and acceptability of the app. Aim 2 will involve a 2-group (AC vs SC), pilot randomized control trial to test the feasibility, acceptability, and preliminary efficacy of Re-Connect.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants
Participants will be told how they can earn back access to their applications but they will not be told whether this is considered the active or control condition.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Abstinent Contingent (AC) Re-Connect

Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO\<=6ppm).

Group Type EXPERIMENTAL

Abstinent Contingent (AC) Re-Connect

Intervention Type BEHAVIORAL

Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO\<=6ppm).

Submission Contingent (SC) Re-Connect

Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence.

Group Type ACTIVE_COMPARATOR

Submission Contingent (SC) Re-Connect

Intervention Type BEHAVIORAL

Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Abstinent Contingent (AC) Re-Connect

Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO\<=6ppm).

Intervention Type BEHAVIORAL

Submission Contingent (SC) Re-Connect

Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* individuals who report smoking at least 10 cigarettes per day for at least 2 years, -18 years of age or older
* do not have any health complications that might interfere with the study or require more intensive treatment (e.g., emphysema, chronic obstructive pulmonary disorder, asthma, lactose intolerance)
* report a strong desire to quit smoking (8 or higher on a 10-point Likert scale)
* has prior experience using a smartphone, speak English, and are literate, will be eligible for the study.

Exclusion Criteria

* Individuals with mental health complications that are either un-managed or that have been managed for less than 6-months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Kentucky

OTHER

Sponsor Role collaborator

Rowan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bethany Raiff, PhD

Role: PRINCIPAL_INVESTIGATOR

Rowan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rowan University

Glassboro, New Jersey, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bethany Raiff, PhD

Role: CONTACT

856-256-4500 ext. 53782

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bethany Raiff, PhD

Role: primary

856-256-4500 ext. 5-3782

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRO-2020-123

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smartphone Based Smoking Cessation Intervention
NCT03740490 COMPLETED PHASE2/PHASE3
Smoking Cessation in Alcoholism Treatment
NCT00000454 COMPLETED PHASE4
Mobile Contingency Management for Smoking Cessation
NCT04881630 ACTIVE_NOT_RECRUITING NA
Early Tobacco Abstinence - 5
NCT00224965 TERMINATED PHASE1
Goal2Quit + NRT Sampling
NCT03837379 COMPLETED NA